Coagulation and Fibrinolysis Dysregulation in β-Thalassemia Major: Potential Impact of Splenectomy and Medications on Thrombotic Risk
Objective The dysregulation of clotting factors in β-thalassemia major is not fully understood. This case-control study examines the impact of splenectomy and medications on clotting factor dysregulation. Methods Lab. tests of coagulation and fibrinolysis were performed. Results This study included...
Saved in:
Main Authors: | Ola M. Al-Sanabra PhD, Manal A. Abbas PhD, Wafà J. Hazà MS, Abeer A. Hazàa MS, Ahmad K. Al Tibi MS |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-07-01
|
Series: | Clinical and Applied Thrombosis/Hemostasis |
Online Access: | https://doi.org/10.1177/10760296251359291 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Splenectomy in Pregnant Patient with Sickle Beta-Thalassemia
by: Adel F. Al-Marzouki, et al.
Published: (2025-04-01) -
Identification of Coagulation and Fibrinolysis-Associated Biomarkers With Implications for Preeclampsia
by: Yujie Liu, et al.
Published: (2025-01-01) -
Immune Response of Thalassemia Major Patients in Indonesia with and without Splenectomy
by: Teny T Sari1, et al.
Published: (2016-05-01) -
Immune Response of Thalassemia Major Patients in Indonesia with and without Splenectomy
by: Teny T Sari1, et al.
Published: (2016-05-01) -
Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation
by: Rune Schjetlein, et al.
Published: (1997-06-01)